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The variable array of pattern receptor expression in diﬀerent cells of the innate immune system explains the induction of distinct
patterns of arachidonic acid (AA) metabolism. Peptidoglycan and mannan were strong stimuli in neutrophils, whereas the fungal
extract zymosan was the most potent stimulus in monocyte-derived dendritic cells since it induced the production of PGE2,
PGD2, and several cytokines including a robust IL-10 response. Zymosan activated κB-binding activity, but inhibition of NF-κB
was associated with enhanced IL-10 production. In contrast, treatments acting on CREB (CRE binding protein), including PGE2,
showed a direct correlation between CREB activation and IL-10 production. Therefore, in dendritic cells zymosan induces il10
transcription by a CRE-dependent mechanism that involves autocrine secretion of PGE2, thus unraveling a functional cooperation
between eicosanoid production and cytokine production.
1. Polymorphonuclear Leukocytes and
Eicosanoid Production
Myeloid cells are unique cell types as regards their content
of high amounts of esterified arachidonic acid (AA) and
the enzymes necessary to metabolize free AA into diﬀerent
products via cyclooxygenase and lipoxygenase pathways.
However, unlike mast cell, which readily respond to cross-
linking FcεRI receptors, and platelets, which release AA in
response to classical aggregating agents, less information
is available about the physiologically relevant stimuli in
polymorphonuclear leukocytes (PMN) and macrophages,
since most experiments have been carried out either with
xenobiotics or combining chemoattractants with chemicals
and priming agents. An example of the first setting has
been the use of calcium ionophores. An example of the
second situation has been the use of formylated peptides in
combination with cytochalasin B and thapsigargin, which
extend the time span of calcium transients and allow the
occurrence of Ca2+ dependent events such as translocation
of the cytosolic phospholipase A2 (cPLA2) from the cytosol
to lipid bilayers [1–4]. However, this scenario has suddenly
changed with the emergence of new views on the function
of the immune system based on the recognition of microbial
patterns.
1.1. Polymorphonuclear Leukocytes Release Arachidonic Acid
in Response to Ligands of Pattern Recognition Receptors. PMN
are the first blood cell type able to migrate into tissues follow-
ing microbial invasion. PMN respond to a large set of stimuli,
including inflammatory mediators and microbial products.
This group of stimuli is most relevant, since microorganisms
have unique molecules, termed pathogen-associated molecu-
lar patterns (PAMPs), which are recognized through pattern
recognition receptors (PRRs) by the host innate immune sys-
tem. The Toll-like receptor family (for review, see [5, 6]) and
nucleotide-binding oligomerization domain family proteins
(NOD) (for review, see [7, 8]) are representative of what
Janeway first called PRR [9]. C-lectin type receptors are also
PRR that may interact with structural signatures expressed
in microorganisms. Experiments in human PMN using as
stimuli a set of PAMP signatures including the mannose
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polymer mannan and peptidoglycan (PGN), a polymer of
sugars and amino acids that forms a mesh-like layer outside
the plasma membrane of bacteria, showed a robust release
of [ 3H]AA (Figures 1(a) and 1(b)) and the production of
leukotriene (LT) B4 and prostaglandin (PG) E2 (Figures 1(c)
and 1(d)). The release of [ 3H]AA observed under these
conditions was not blunted by calpeptin, an inhibitor of the
formation of microvesicles, but was inhibited by treatment
with the cPLA2 inhibitor pyrrolidine-1. The released product
was identified as genuine unesterified AA by thin layer
chromatography analysis, since the radioactivity detected in
the supernatants showed a RF distinct from that associated
with [ 3H]triglycerides and [ 3H]phospholipids, which were
only observed associated with the cell pellets. The release
of AA obtained under these conditions was comparable to
that elicited by the so far considered reference stimuli such
as the formylated peptide combined with thapsigargin or
cytochalasin B, and complement-coated zymosan particles.
In sharp contrast, stimuli mimicking other bacterial PAMP,
that is, lipoteichoic acid, bacterial lipopolysaccharide (LPS),
muramyldipeptide (MDP), and the TLR2 agonist Pam3CSK4
did not induce AA release [10].
The eﬀect of PGN was observed with PGN from both S.
aureus and B. subtilis, thus indicating that PGN displaying
the structural features of both Gram + and Gram − bacteria
are equally active. Preincubation of PMN with anti-TLR2
mAb prior to the addition of PGN did not inhibit AA release,
thus suggesting that TLR2 receptors are not involved in
the response to PGN. Consistent with this result, Barrett
et al. [11] reported TLR2-independent cysteinyl-LT release
from mouse bone marrow dendritic cells stimulated with
PGN, since the response was intact in TLR2−/− mice. The
assignment of the biological eﬀect of PGN to definite PRR
has been a matter of debate [12, 13]. Both TLR and NOD
receptors have been involved and the controversy stems
from the assignment of the biological properties to either
the PGN polymer or the block elements MDP and D-
glutamic acid-meso diaminopimelic acid. Molecular weight
fractionation of S. aureus PGN showed the association of
AA-releasing activity with fractions of molecular weight
>30 kDa, whereas no activity was detected in the <30 kDa
ultrafiltrate, which is consistent with the Mr of soluble PGN.
The biological significance of the lipid mediators release by
PMN in response to TLR ligands was recently underscored
in an in vitro model of migration through endothelial cell
monolayers. In this system, PMN migration was inhibited by
LTB4 receptor antagonist and platelet-activating factor (PAF)
receptor antagonists and was associated with the production
of these mediators [14].
1.2. Mechanism of Cyclooxygenase-2 Expression Induction in
Human PMN. Current understanding of PMN biology has
been modified by recent findings indicating that the life span
of PMN can be prolonged by proinflammatory agonists [15],
and also by the depiction of mechanisms of translational
control of the expression of specific proteins that endow
the PMN with the potential for rapid protein synthesis
from constitutive mRNA without requiring new transcript
generation [16–18]. The possibility that this mechanism
could be operative in PAMP-dependent responses and might
influence AA metabolism through the expression of COX-2,
was a challenging hypothesis.
Since PGE2 is a major product resulting from AA in
the PMN (Figures 1(c) and 1(d)) that can be produced
both by COX-1, the constitutive isoform of cyclooxygenase,
and COX-2, the inducible isoform, the eﬀect of a set of
PAMP signatures on the expression of COX-2 was addressed.
Unexpectedly, preformed mRNA encoding for COX-2 was
detected in resting PMN, whereas COX-2 protein was only
detectable after stimulation with either mannan or PGN
[19]. COX-1 protein showed the same level of expression
in the absence and presence of several stimuli, but well
below the level detected in platelets, which are the archetypal
source of COX-1. Pam3CSK4 showed a less robust eﬀect and
lipoteichoic acid, an agonist of TLR2/TLR6 heterodimers,
did not elicit COX-2 protein induction. MDP, which is
the archetypal ligand for NOD2, also failed to induce
COX-2 expression. Since interaction between NOD2 and
specific TLR pathways has been reported as a mechanism
of cooperation in the innate immune response that lead to
the synergistic activation of host cells [20–22], the eﬀect of
the combined addition of both S. aureus PGN and MDP
was assessed. This combination of agonists did not modify
the eﬀect elicited by PGN alone. The induction of COX-2
protein by PGN was observed as soon as 30 minutes after
addition of the stimulus and remained almost unchanged
from 1 to 18 hours. A similar trend was observed for both
C3bi-coated zymosan and mannan, although a decreasing
tendency was observed around 18 hours in response to these
ligands. These results indicate that PGN contains a structural
signature not acting on NOD2 nor mimicked by lipoteichoic
acid and Pam3CSK4, which could act via the TLR route in
combination with an additional catch-up receptor(s) and/or
by an as yet ill-defined TLR2-independent route.
Since PMN are terminally diﬀerentiated cells that con-
tain regulators of transcriptional control and show signal-
dependent activation of mRNA translation [17, 18], the
hypothesis that COX-2 mRNA could be one of those mRNA
controlled in the same manner was put forward. Contrary
to this view, one could argue that the calculation of the
predicted secondary structure energy of the 5′-untraslated
region (UTR) of COX-2 mRNA is −36.94 kca/mol, as judged
from the application of RNAfold software [23, 24] to
sequences available in data banks (Figure 2(a)). This value
is lower than that usually associated with transcriptional
regulation (−50 kcal/mol); however, it fits well with those
reported for many transcripts detected using cDNA library
arrays which are regulated at the transcriptional level in
human monocytes adherent to P-selectin [25]. Moreover, the
presence of four tracts of 5–8 consecutive pyrimidine bases
is an additional feature strongly suggesting the possibility
of translational control by mammalian target of rapamycin
(mTOR). The presence of the 5′-UTR in COX-2 transcripts
in human PMN was confirmed by RT-PCR with a set of
primers spanning the first 20 nucleotides of exon 1 and exon
2 of COX-2, which gave similar results to PCR reactions
using the primers selected from exons 5 and 7 (Figure 2(b)).
Preincubation of PMN with 100 nM rapamycin inhibited
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Figure 1: Distribution of [ 3H]AA label in the diﬀerent lipid fractions in PMN and supernatants. PMN at a concentration of 107 cells/ml were
labelled with 0.2 μCi of [ 3H]AA and stimulated for 1 hour in the presence of 10 μg/ml PGN or 25 mg/ml mannan, or left untreated. PMN
and supernatants were subjected separately to extraction in chloroform/methanol (1 : 2, v/v), according to the Bligh and Dyer procedure.
The lipids extracted into the chloroform layer were dried under N2 stream and developed by thin layer chromatography on silica gel plates in
the system n-hexane/diethyl ether/acetic acid (70 : 30 : 1, v/v). The radioactivity distributed in the diﬀerent lipid fractions was quantitated
using K/tritium imaging screens. The migration of the standards is indicated (a). Cells were incubated with calpeptin and pyrrolidine-
1 prior to the addition of the stimuli and the [ 3H]AA released into the cell supernatants assayed. Data represent mean ± SEM of three
experiments in duplicate. ∗P < 0.05. Reproduced with permission [10] (b). Chromatogram of a supernatant of human PMN stimulated
with mannan showing the retention times of PGE2/PGD2 and 20-OH-LTB4. Both compounds have been identified by their mass spectra
(c). Fragmentation spectra in the negative ion model using MRM (multiple reaction monitoring) of the specific transitions m/z 335–195 for
LTB4, m/z 351–195 for 20-OH-LTB4, m/z 303–205 for arachidonic acid, m/z 351–189 for PGE2/PGD2 are shown in (d).
the induction of COX-2 elicited by complement-coated
zymosan, PGN, and mannan, thereby suggesting that the
mTOR route is implicated in the translational regulation of
COX-2 protein induction. Given that mTOR is integrated
in a signalling cascade, the proximal component of which
is phosphoinositide-3 kinase (PI3K), the eﬀect of the PI3K
inhibitor wortmannin was addressed. A significant inhibi-
tion of COX-2 induction was produced by wortmannin as
well as by the translation inhibitor cycloheximide. PGN
also induced a time-dependent threonine phosphorylation
of eIF4E binding protein. This provides further evidence of
the involvement of the mTOR route, since the phospho-
rylation of this translation inhibitor by mTOR disrupts its
binding to eIF4E and activates cap-dependent translation
[26].
Additional mechanisms of COX-2 mRNA regulation
were explored using transcription inhibitors. Actinomycin D
did not influence the induction of COX-2 protein elicited by
mannan and PGN, whereas it fully inhibited the response
to LPS. Since COX-2 mRNA stability in some cell types
is regulated at the 3′-UTR, PMN were incubated in the
presence and absence of 1 μg/ml actinomycin D for 30
minutes before the addition of PGN to address the half-
life of COX-2 mRNA. In the absence of actinomycin D,
53 ± 7% of the starting COX-2 mRNA was detected in
control cells versus 70 ± 9% (mean ± SD, n = 3) in
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Figure 2: Sequence of the 5′-UTR of COX-2. The sequence and the predicted secondary structure of the 5′-UTR of COX-2 calculated using
RNAfold software are shown. Polypyrimidine tracts are underlined in the sequence (a). Agarose gel electrophoresis of PCR reactions in
RNA obtained from resting PMN using diﬀerent combinations of primers (b). Stick diagrams show the location of primers used for PCR
reactions, and the lanes are marked according to the combination of primers selected to carry out the reactions. FP indicates forward primer,
RP indicates reverse primer. Reproduced with permission [19].
cells treated with PGN for 2 hours after addition of the
stimulus. Actinomycin D treatment induced a further drop
of the remaining mRNA in vehicle treated cells, whereas
this additional drop was hardly observed in PGN-treated
PMN. Further assessment of transcriptional regulation of
COX-2 expression was carried out by looking at the eﬀect
of 2-hydroxy-4-trifluoromethylbenzoic acid, an inhibitor of
both NF-κB and NF-AT [27, 28], which is a useful tool
to address in a single step transcriptional regulation since
both transcription factors have been involved in COX-
2 regulation in diﬀerent cell types [29, 30]. Hydroxy-4-
trifluoromethylbenzoic acid lacked a significant eﬀect on
COX-2 protein expression in response to all of the stimuli
tested. Taken collectively, these data suggest that transcrip-
tional regulation is not the main mechanism whereby COX-2
expression is regulated in human PMN.
To ascertain whether the above described mechanisms
are either a unique property of PMN or are also operative in
other myeloid cells, COX-2 protein expression was assayed in
monocytes; however, the time course was somewhat diﬀerent
from that observed in PMN, since COX-2 protein steadily
increased up to 4–8 hours. Unlike PMN, rapamycin did not
influence COX-2 protein expression in monocytes nor in
macrophages, whereas actinomycin D significantly blocked
COX-2 protein induction expression in response to zymosan,
mannan, PGN, and the soluble β-glucan laminarin. These
results strongly suggest that diﬀerent mechanisms can be
involved in COX-2 regulation in PMN and mononuclear
phagocytes.
2. TheMacrophage and Dendritic Cell System
Uptake of phagocytosable particles is strongly dependent
on the expression of receptors involved in the recognition
of serum proteins displaying opsonic functions such as
complement factors and antibodies. This is relevant to the
engulfment of fungi and bacteria since these microbes can
be coated by the complement factor 3 derived protein
C3b and by opsonic IgG class antibodies. The display of
receptors on the diﬀerent cell types including FcγR receptors,
complement receptors, and PRR is a key factor to determine
the inflammatory and phagocytic responses and it can widely
vary among diﬀerent cell types (Figure 3). In addition,
signals elicited upon binding of receptors by their cognate
ligands may be balanced by concomitant signals induced by
associated PAMP or from the environment, or even by the
expression of cell-specific adaptors [31]. This is particularly
relevant to mononuclear phagocytes in view of the diﬀerent
patterns of diﬀerentiation they may undergo due to the
presence of cytokines and growth factors in the inflammatory
milieu.
2.1. The Opposing Eﬀect of C3bi-Coating of Immune Com-
plexes and Zymosan Particles on AA Release. AA metabolism
was assessed in mononuclear phagocytes stimulated with
antigen/antibody immune complexes and zymosan, a cell
wall extract of the yeast Saccharomyces cerevisiae. Since
formation of immune complexes (IC) in fluids containing
complement is accompanied by the covalent linkage of
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Figure 3: Cells and receptors involved in AA metabolism in the innate immune system. PMN respond to cooperative binding of dectin-1 and
CR3, to the cross-linking of FcγR, to mannose-based PAMP, and to G-protein-coupled receptors (GPCR) in the presence of priming agents.
The receptor involved in the response to PGN has not been characterized as yet. Macrophages express a similar array of receptors showing
productive binding. In DC the most eﬃcient response is obtained by triggering dectin-1 and DC-SIGN by PAMP containing β-glucan and
mannose polymers, respectively.
C3bi onto the Ab and because C3bi coating of zymosan
is known to increase inflammatory responses [32] and AA
release in leukocytes [33], experiments were carried out with
preformed IC treated with normal human serum to allow the
formation of adducts between IgG γ-chain and C3b-α-chain,
a process that has been related to the clearance of IC with
a limited inflammatory response. Notably, the AA released
by C3bi-IC was significantly lower than that induced by IC
containing similar amounts of IgG, thus suggesting that the
reaction of IC with C3bi gives rise to an IC lattice showing
a distinct ability to interact with signaling receptors. The
most likely interpretation of these findings is that the ability
of C3bi-IC to interact with complement receptor 3 (CR3)
blunts Fc/FcγR interactions and the attendant AA release
associated with FcγR cross-linking. Treatment of C3bi-IC
with anti-C3 IgG, but not with an irrelevant rabbit IgG,
allowed the recovery of AA-releasing ability, thus indicating
that masking the C3bi moieties with IgG in the C3bi-IC
lattice, makes these complexes similar to those formed in
the absence of complement [34]. Conversely, removal of the
Fc portion of anti-OVA IgG, which preserves the ability of
the F(ab′)2 fragment to bind covalently C3bi on the Ser-132
of the CH1 domain [35], abrogated AA-releasing activity,
thus indicating that Fc-FcγR interaction is essential for IC-
induced AA release and that stimulation through C3bi does
not elicit productive binding in this system.
2.2. The Role of the Mannose Receptor in Human Monocytes.
The mannose receptor (MR), first described by Stahl et al.
[36] has been the object of detailed analysis regarding its
ability to initiate the uptake of glycosylated molecules with
terminal mannose, fucose, or N-acetylglucosamine moieties.
Its capacity for ligand recognition makes this receptor suit-
able to phagocytose Candida albicans, Leishmania donovani,
and Pneumocytis carinni, among other microorganisms [37–
39]. The MR is the prototypic element of a homonymous
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family of C-type lectin receptors, which includes the secreted
phospholipase A2 M-type receptor, the dendritic cell receptor
DEC-205, and Endo180/urokinase plasminogen-activated
receptor-associated protein. These receptors contain carbo-
hydrate recognition domains, although the chemical struc-
ture of the ligands interacting with those domains shows
wide diﬀerences. The MR is mainly expressed in alveolar
macrophages, peritoneal macrophages, and macrophages
derived from blood monocytes [40] and seems to play a role
in the early immune response against invading pathogens.
Although the MR was shown to participate in intracellular
signalling leading to target gene expression, the absence of
signaling motifs in its intracellular tail makes it necessary
the assistance from other receptors in order to trigger any
signalling cascade. The MR has been found to exert some
eﬀect on the induction of eﬀector Th17 cells in mixed
leukocytes populations [41] and binding of the mannose
polymer mannan to the MR induced a mild expression of
COX-2 protein above basal levels, whereas treatment with
laminarin, zymosan particles, and preformed IC failed to
do so. Notably, monocyte-derived macrophages obtained
after two weeks of culture showed a prominent induction
of COX-2 protein with concentrations of mannan as low
as 0.1 mg/ml, thus suggesting that recognition of mannose-
based molecular patterns by macrophages might play a
central role in the induction of the innate immune response
[42].
2.3. AA Metabolism in Monocyte-Derived Dendritic Cells.
The main function of dendritic cells (DC) is the detection
of pathogens and the initiation of the host response to
microbial invasion. So far, few studies have been dedicated
to the analysis of the production of AA metabolites [43], in
spite of the relevant role of eicosanoids in DC function and
the prominent changes in lipid metabolism elicited by M-
CSF and IL-4 along the process of monocyte diﬀerentiation
[44]. In addition, PGE2 is required for human DC migration
in response to chemokines [45, 46], and consistent with
this pivotal function, failure of DC to produce PGE2
has been considered a major obstacle for the successful
application of DC in therapy [47, 48]. PG biosynthesis
involves several steps catalyzed by diﬀerent enzymes, but it
depends primarily on the availability of free AA selectively
released from phospholipids by cPLA2. COX-2 is involved
in the sustained production of prostanoids, the activity
of which is necessary for strong Ab response following
vaccination [49]. In addition to the COX-2 route for AA
metabolism, there are pathways dependent on constitutively
expressed 5-lipoxygenase and COX-1, which are triggered
shortly after cell activation. As regards 5-lipoxygenase prod-
ucts, deficient extracellular export of LTC4 is associated
with a decreased migratory response of DC [50], whereas
cysteinyl-LT increase IL-10 production by myeloid DC [51].
Recent studies have disclosed lipoxins as a unique class of
lipoxygenase interaction metabolites with a strong ability to
suppress the production of IL-12 and the function of DC
[52].
In keeping with the changes in functional parameters
observed upon DC diﬀerentiation, AA metabolism in DC
showed diﬀerent patterns in mature and immature DC.
Whereas the release of AA elicited by zymosan and other
ligands showed no diﬀerence between immature and TNFα-
mature cells, increased expression of COX-2 was only
observed in immature dendritic cells. Unlike PMN and
monocytes, zymosan particles were the most potent stimulus
for AA release, which was observed with concentrations as
low as 0.1 mg/ml. In contrast, mannan induced AA release
to a lower extent. Unlike the results observed in monocytes,
neither C3bi coating nor opsonization with rabbit IgG
modified the ability of these stimuli to release AA [53].
This raises important question about the recognition of
β-glucan particles and the coupled signaling mechanisms
in diﬀerent cell types. In fact, the main receptor involved
in β-glucan recognition is dectin-1, which is expressed on
the cell surface of PMN, monocytes, and DC; however,
DC display a unique response to zymosan particles. At
first glance, two mechanisms might explain the diﬀerent
responses: (i) expression in some myeloid cell types of
an inhibitor, for example, tetraspanin CD37, that restricts
dectin-1-CARD9 signaling [31], or (ii) gain of function
of DC by diﬀerentiation-induced expression of a receptor
cooperating with dectin-1.
Zymosan-induced AA release was inhibited by laminarin,
mannan, and anti-dectin-1 and anti-DC-SIGN mAb, spe-
cially when the inhibitors were used in combination. These
data would suggest cooperation of both dectin-1 and DC-
SIGN in zymosan-induced AA release and would agree with
the aforementioned hypothesis of the selective expression
in DC of a receptor not expressed in other myeloid cell
types. To obtain further insight into the type of receptors
involved in the recognition of zymosan by DC, the binding
of Alexa-Fluor 488 zymosan was studied in the presence
of diﬀerent inhibitors. Mannan, laminarin, anti-DC-SIGN
mAb, and anti-dectin-1 mAb blocked zymosan binding, but
combination of these inhibitors enhanced binding blockade.
Taken together, these data show the existence of a cPLA2-
dependent route for AA release in DC that is triggered by the
binding of zymosan to dectin-1 and DC-SIGN.
2.4. Syk Activity Is Involved in AA Release. Protein tyrosine
phosphorylation reactions play a central role in cell signaling
through both FcγR and dectin-1 in murine DC [54, 55].
Since these receptors do not possess intrinsic enzymatic
activity, their signal transduction pathways must rely on
activation of nonreceptor tyrosine kinases. This explains why
the Syk/Zap70 family member Syk has been found to be
critical for linking receptor engagement to many early down-
stream events including calcium mobilization and activation
of the Ras/mitogen-activated protein kinase pathway. The
involvement of Syk in AA release and COX-2 induction
in murine macrophages was first reported by Suram et al.
[56], who also showed that AA release and LTC4 production
stimulated by zymosan and Candida albicans were TLR2-
independent. Studies in human DC were addressed by
examining tyrosine phosphorylation of the kinase (a measure
of Syk activation) and the eﬀect of Syk inhibitors. Both IC
and zymosan induced the phosphorylation of tyrosines in
the activation loop of Syk and Syk inhibitors significantly
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blunted AA release. However, Syk inhibitors only partially
aﬀected zymosan-induced cPLA2 phosphorylation [53] and
the Syk inhibitor piceatannol blunted the release of AA by
96% and 54% in response to IC and zymosan, respectively.
R406, a very specific Syk inhibitor, also inhibited completely
the response to IC and reduced zymosan-induced AA release
by 30%. Zymosan-induced Syk phosphorylation was also
inhibited with the addition of laminarin, but not by anti-DC-
SIGN mAb. Taken collectively, these results are consistent
with the notion that Syk activity is completely necessary for
IC-induced AA release, but it is only partially involved in the
signalling mechanism whereby zymosan elicits AA release in
DC.
2.5. DC-SIGN Coimmunoprecipitates with Dectin-1. The
inhibition of AA release by combinations of laminarin/anti-
dectin-1 and anti-DC-SIGN mAb suggested cooperation
between DC-SIGN and dectin-1. This was confirmed by
showing that dectin-1 coimmunoprecipitated with DC-
SIGN, particularly after the stimulation of DC with zymosan
(Figure 4). Additional experiments in HEK293 cells trans-
fected with vectors encoding DC-SIGN and Myc-dectin-1
showed a robust coimmunoprecipitation of both C-lectin
receptors when immunoprecipitation was carried out with
either anti-DC-SIGN mAb or anti-Myc mAb. These results
are consistent with a system for zymosan recognition in
DC involving the interaction of dectin-1 and DC-SIGN.
Studies by confocal microscopy confirmed these findings
by showing DC-SIGN clusters in areas of contact with
zymosan particles, but not around engulfed particles as
judged from the analysis of images taken after 10 minutes,
where ingested particles were not surrounded by DC-SIGN
staining (Figure 5). This finding agrees with recent reports
indicating that DC-SIGN is a mannan-inhibitable zymosan
receptor, but does not mediate phagocytosis [57, 58]. In
contrast, engulfed zymosan particles were clearly surrounded
by dectin-1. Taken collectively, these data would suggest
that the diﬀerentiation of human monocytes into DC is
accompanied by the induction of DC-SIGN, a receptor that
cooperates with dectin-1 to elicit an active metabolism of
AA. Further support of the role played by changes associated
to the process of DC diﬀerentiation on AA metabolism is
the enhancement of dectin-1-mediated AA release in alveolar
macrophages by GM-CSF, a cytokine used to promote
DC diﬀerentiation [59]. In sharp contrast, rat peritoneal
macrophages respond to zymosan particles by promoting
the mobilization of both type IIA phospholipase A2 and
cPLA2 into the phagosomes in the absence of growth factors
and cytokines [60, 61]. Taking collectively, these findings
underscore the importance of environmental factors on the
ability of mononuclear phagocytes to regulate the catalytic
properties of phospholipases A2. A diagram of the signaling
routes involved in AA metabolism in DC stimulated with
fungal stimuli is shown in Figure 6.
2.6. AA Metabolites and the Release of Cytokines from DC.
Fungal PAMP acting through dectin-1 and DC-SIGN induce
a cytokine response characterized by a high production
of IL-10 and IL-23, and a low secretion of IL-12 p70
[55, 62, 63], as compared to the eﬀect on IL-12 p70
production of archetypal TLR4 agonists. This fact may
have pathophysiological consequences for the persistence of
infection and raises the question of the signaling pathways
involved in the predominant IL-10 response. The regulation
of IL-10 production has been the subject of intense research
in TLR4-dependent models and both transcriptional and
posttranscriptional mechanisms have been reported. As
regards transcriptional regulation, many transcription fac-
tors have been considered as master regulators, namely Stat3
[64–67], Sp1 and Sp3 [68, 69], c-Maf [70], NF-Y [71],
NF-κB [72–74], Pbx1b (pre-B cell leukemia transcription
factor-1b) [75], c/EBP [76], NFAT [77, 78], and CREB
[79, 80]. In addition, posttranscriptional regulation of IL-
10 message has also been proposed because of the high
number of AU-rich elements in the 3′-UTR of IL-10
mRNA [81] and their binding by the RNA-binding protein
tristetraprolin, which destabilizes the message [82]. After
addressing the stability of IL-10 mRNA in the presence
of actinomycin D, it was concluded that the regulation
of IL-10 expression is best explained by transcriptional
mechanisms [83]. Computer analysis of human and mouse
il10 promoters was carried out using the MatInspector
program and the TRANSFAC database to detect binding
sites for transcription factors. In addition, both sequences
were aligned with DNA Block Aligner software to define
conserved areas, since these regions are more likely to
represent functionally relevant elements. Several of the sites
detected were previously associated with the transcriptional
regulation of il10, but there have been some discrepancies
regarding their functional relevance and studies with fungus-
related stimuli have not been reported. The first approach
was to search for the presence of binding activities to the
consensus strings of the transcription factors found in the
human il10 promoter. No binding activity to Stat and C/EBP
consensus sequences was observed in the nuclear extracts of
cells treated with zymosan, whereas binding activity to Stat1
and Stat3 was elicited by IFN-α. Constitutive binding activity
to Sp sites compatible with both Sp1 and Sp3 was detected,
as well as binding activity to CRE consensus sequences.
NF-κB is activated by zymosan and has been associated
with the regulation of il10 in mouse macrophages [72–74]
and with the regulation of COX-2. Taking into account
that the expression of COX-2 parallels IL-10 induction,
experiments were conducted using probes containing the
κB sites from the human cox2 promoter that have found
to be of functional relevance. Zymosan and LPS were
strong activators of NF-κB binding activity to cox2 sites.
The response to zymosan was dose-dependent and binding
was competed by the unlabeled sequence. However, as the
sequence involved in NF-κB-dependent regulation of il10
expression in the mouse is not conserved in the human
il10 promoter, the appearance of κB-binding activity in the
nuclear extracts upon zymosan challenge is not a proof of the
involvement of NF-κB in the regulation of IL-10 expression
in human DC. Altogether, the above-mentioned results did
not support the involvement of Stat1, Stat3, and c/EBP in the
regulation of IL-10 induction and further experiments were
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Figure 4: Coimmunoprecipitation of dectin-1 and DC-SIGN. DC were incubated in the presence and absence of 1 mg/ml zymosan for 10
minutes and then the cell lysates were used for immunoprecipitation with either 5 μg anti-DC-SIGN or 5 μg anti-glutathione S-transferase
(GST) control mAb and blotting with anti-DC-SIGN, anti-dectin-1, or anti-GST Ab (a). HEK293 cells were transfected with the indicated
expression vectors and the cell lysates immunoprecipitated with either 2 μg anti-DC-SIGN or 0.5 μg anti-Myc mAb (b). Upper panels
show the expression of the Myc tag and DC-SIGN in the immunoprecipitates. The lower panels show the expression of the proteins in
the cell lysates. Cells transfected with pEF4 empty vector were used where no expression vector is indicated. Immunoprecipitations have
been conducted with 2 mg protein per condition. The lanes corresponding to cell lysates were loaded with 40 μg protein. Reproduced with
permission [53].
conducted focusing on the possible involvement of NF-κB
and CREB.
2.7. Eﬀect of the Pharmacological Modulation of CREB and
NF-κB Activities on IL-10 Production. Since the activity of
CREB and NF-κB can be modulated by pharmacological
tools, experiments were conducted with 8-Br-cAMP, a cell
permeable analogue of cyclic AMP, PGE2, and the protein
kinase A inhibitor H-89. Elevation of the intracellular levels
of cyclic AMP by both PGE2 and 8-Br-cAMP had on its own
a limited eﬀect on IL-10 production, whereas stimulation
with zymosan in the presence of these compounds produced
a synergistic increase of IL-10 production. Notably, the
opposite eﬀect was observed in the presence of the protein
kinase A inhibitor H-89. In contrast with the eﬀect of the
chemicals producing inhibition of CREB activity, blockade
of NF-κB activity by two structurally unrelated inhibitors
was accompanied by an increase of IL-10 production.
Since the regulation of CREB activity has been related
to calcium/calmodulin kinases and CRE coactivators, the
activity of which depends on a sensor of both Ca2+ and cyclic
AMP levels [84], the Ca2+-dependence of IL-10 production
was addressed. IL-10 production was blunted by Ca2+-
chelation. Ionomycin induced a limited production of IL-
10, thus suggesting that intracellular Ca2+ levels are not
the only factor determining IL-10 production. Moreover,
low micromolar concentrations of cyclosporin induced a
significant decrease of IL-10 production, thus pointing to
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Figure 5: DC-SIGN and dectin-1 cluster around zymosan particles. DC at a concentration of 5 · 105 cells/ml were layered over glass
coverslips and incubated with Alexa-Fluor 488 (green) labeled zymosan particles (5 particles per cell) for diﬀerent times at 37◦C. Anti-
DC-SIGN mAb and goat anti-mouse IgG Ab labelled with Alexa-Fluor 594 (red) were used for staining DC-SIGN. Note that upon zymosan
stimulation, DC-SIGN clusters around zymosan, but not around engulfed particles inside the cell (arrowheads) (a). DC were treated with
anti-dectin-1 mAb and goat anti-mouse IgG Ab labelled with Alexa-Fluor 594 (b). Cells incubated in the absence of zymosan particles were
stained for DC-SIGN and dectin-1 (c, d). Cells incubated in the presence of zymosan particles were assayed for CD45 staining at the times
indicated (e). Reproduced with permission [53].
the involvement of calcineurin in the regulation of IL-
10 production. Since E prostanoid receptors type 2 and
4 are involved in the regulation of the intracellular levels
of cyclic AMP and zymosan is a strong inducer of COX-
2 and PGE2 production, the eﬀect of inhibiting COX-
1 with the specific inhibitor SC560 and COX-2 with the
specific inhibitor NS398 was addressed. The isolated addition
of any of those compounds at concentrations of ∼ 1 μM
to preserve their selectivity, did not show any significant
eﬀect on IL-10 production. Notably, combination thereof
produced a significant inhibition, thus suggesting that both
COX isoforms might be involved in an autocrine production
of PGE2 that regulates intracellular cyclic AMP levels and
zymosan-induced IL-10 production. Taken together, these
results suggest that the polarization of DC cytokine response
versus IL-10 production in response to the fungal surrogate
zymosan depends on a fine-tuned balance between NF-κB
and CREB activity, and that PGE2 plays a role in this balance.
2.8. The Role of Diﬀerent Transcription Factors on IL-
10 Induction. To address directly the involvement of the
distinct transcription factors on IL-10 regulation, chromatin
immunoprecipitation (ChIP) assays were conducted using
antibodies reactive to P-CREB, CBP, c-Maf, NF-YA, Sp1, and
Pbx1. Significant binding of P-CREB to the il10 promoter
was observed in DC stimulated with zymosan, but not
in control cells nor in samples treated with an irrelevant
antibody. Notably, this was associated with a 64-fold increase
of the amount of CBP associated to the il10 promoter,
thus suggesting that zymosan induces both binding of P-
CREB to CRE sites and recruitment of the coactivator CBP.
ChIP was negative when the PCR reactions were carried
out using primers from the IL12 p35 promoter, which
does not contain CRE sites. P-CREB binding was also
detected in the cox2 promoter upon zymosan stimulation,
which agrees with the presence of two CRE sites in this
promoter and with the functional relevance of these sites
in cox2 transcriptional regulation [85, 86]. Binding of P-
CREB and CBP to the promoters was coincidental with
the detection of TORC2 (transducer of regulated CREB
activity), a CREB coactivator also known as CREB-regulated
transcription coactivator (CRTC), in the nuclear extracts. In
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Figure 6: Diagram of AA metabolism in DC stimulated with
zymosan particles. The mannan and β-glucan components of
zymosan are recognized by at least DC-SIGN, TLR2, and dectin-1.
This gives rise to a series of signaling events implicating activation
of Syk and Src families of tyrosine kinases. Both routes converge to
activate phospholipase Cγ and through the generation of diacylglyc-
erol activate protein kinase C and mitogen-activated protein kinase
(MAPK) cascades. Phosphorylation by MAPK and Ca2+-driven
translocation of cPLA2 explain AA release from cell phospholipids.
Activation of IκB kinases via MyD88 is a major factor explaining
COX-2 induction. The CARD9/MALT1/BCL10/TRAF6 complex is
involved in the activation of IκB kinases. DAG, diacylglycerol;
IP3, inositol 1,4,5-trisphosphate; PLCγ, phospholipase Cγ; P-Y,
phosphotyrosine.
addition, TORC2 was found to coimmunoprecipitate with P-
CREB.
Expression of the mRNA encoding both the long and
the short form of c-Maf was detected in DC, thus agreeing
with the reported induction of this factor by LPS and IL-
4 in monocytes [70], but binding to the il10 promoter was
not detected by ChIP assays. As regards Sp1 and Sp3, the
detection of binding activity in resting cells was not accom-
panied by binding to the il10 promoter, which agrees with
the notion that this family of transcription factors behaves
as a constitutive activator of housekeeping genes and TATA-
less genes. Stat3 has been associated with il10 transcriptional
activation, especially in response to ligands of TLR4, which
diﬀer from zymosan because of their capacity to activate the
Jak/Stat pathway by TRIF (TIR-domain-containing adapter-
inducing interferon-β)-dependent mechanisms. Stat binding
activity and tyrosine-phosphorylated Stat1 were not detected
in nuclear extracts from zymosan-stimulated DC, whereas
they were induced upon LPS and IFN-γ treatment [87].
These results show a major role for CREB in the transcrip-
tional regulation of il10 in response to the fungal stimulus
zymosan.
2.9. Langerhans Cells and the Th17 Response. The response of
DC to fungal glucans is characterized by a high production
of IL-23 and the development of a Th17 response. This is of
interest because Th17 cells have been implicated in a num-
ber of inflammatory and autoimmune diseases, including
multiple sclerosis, inflammatory bowel disease, asthma and
psoriasis. So far, only preliminary data have suggested the
involvement of lipid mediators in the expansion of Th17
cells. The phospholipid mediator PAF is released in response
to zymosan in many cell types and is found in increased
concentrations in inflammatory lesions. PAF has been shown
to induce the production of IL-6 and the development
of Th17 cells when added at picomolar concentrations to
monocyte-derived Langerhans cells and to keratinocytes.
Moreover, when Langerhans cells (LC) were pretreated with
PAF and then cocultured with anti-CD3- and anti-CD28-
activated T cells, the latter developed a Th17 phenotype, with
a 3-fold increase in the expression of the transcriptional
regulator RORγt and enhanced production of IL-17, IL-21
and IL-22. PAF-induced Th17 development was prevented by
the PAF receptor antagonist WEB2086 and by neutralizing
antibodies to IL-23 and IL-6. It was also dependent on
LC-T cell contact as shown in Transwell experiments [88].
These data suggest that a lipid mediator, the biosynthesis
of which is associated to the eicosanoid cascade, can
stimulate LC to produce IL-6 and IL-23, which, in contact
with TCR-activated T cells, can induce their diﬀerentiation
into Th17 cells. This may constitute a previously unknown
stimulus for the development and persistence of inflamma-
tory processes that could be amenable to pharmacologic
intervention.
3. Concluding Remarks
Release of AA and the sequential production of eicosanoid
are a blatant outcome of PRR binding by their cognate
ligands. The amounts of eicosanoids released under these
conditions make PAMP the most potent and physiologically
relevant stimuli of AA metabolism in myeloid cells. However,
there are a number of significant diﬀerences regarding the
eﬀect of PRR ligands on the diﬀerent cell types, even though
the same types of receptors might be expressed. This raises
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relevant questions regarding the distinct signaling routes
coupled to the receptors, the role of the concomitant expres-
sion of other receptors recognizing the same or other PAMP
present on the same ligand, and the eﬀect of positive and
negative regulators. Of particular interest is the fact that PGN
is the most relevant stimulus in PMN, thus underscoring the
important role played by these cells in the pyogenic infections
produced by Gram+bacteria. Complement coating of PAMP
seems essential for the activation of PMN and monocytes by
particles mimicking the fungal cell wall, whereas monocyte-
derived DC are a cell type specially endowed to respond
to fungal patterns, even in the absence of opsonins. This
property depends on the particular set of receptors expressed
on their membranes, which cooperate to recognize β-glucans
and mannose-containing patterns. The signaling network
triggered by the combined binding of dectin-1 and DC-SIGN
in DC is specially suited for the transcriptional regulation
of a pattern of cytokines characterized by a low production
of IL-12 p70 and a high production of IL-10. This can be
explained by the activation of the transcription factor CREB
through a mechanism involving the coactivators CBP and
TORC2/CRTC2, and autocrine production of prostaglandin
E2. These findings emphasize the need of further work to
transform these mechanistic data into valuable tools to treat
infectious and autoimmune diseases.
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